CLINICAL_TRIALS
trial_result
· 2009-12-09
Clinical Trial Update: Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients [Phase 2]
Summary
Phase 2 trial of pemetrexed plus carboplatin in elderly patients with non-small cell lung cancer has completed, with results posted in 2009.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2009-12-09